Mirum Pharmaceuticals, Inc. (MIRM) Balance sheet

Market cap

$5.8B

P/E ratio

	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	12	142	31	28	286	223
Marketable securities, current	105	90	125	124	-	58
Total cash & short-term investments	117	232	157	152	286	280
Accounts receivable, net	-	-	3	24	68	78
Inventories	-	-	2	6	22	22
Total current assets	119	236	167	190	388	393
Property, plant and equipment, net	1	1	1	1	1	1
Marketable securities, non-current	23	-	5	-	-	13
Total non-current assets	27	5	128	163	259	278
Total assets	147	241	295	353	647	671
Accounts payable	3	3	9	9	7	15
Total current liabilities	13	18	43	65	87	127
Total non-current liabilities	3	50	132	146	311	319
Total liabilities	16	69	174	211	398	445
Common stock and paid-in capital	0	0	0	0	0	0
Retained earnings	-70	-173	-257	-393	-556	-644
Stockholders' equity	130	172	120	142	249	226
Working capital	-	-